IP Library Granted Patent US 8,969,535
Granted Patent B2
US 8,969,535 · App. 13/592,917 · Granted Mar 3, 2015

Photocleavable labeled nucleotides and nucleosides and methods for their use in DNA sequencing

Inventors: Weidong Wu (Houston, TX); Vladislav A. Litosh (Cypress, TX); Brian P. Stupi (Houston, TX); Michael L. Metzker (Houston, TX)
Assignee: Lasergen, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,969,535
App. No.
13/592,917
Granted
Mar 3, 2015
Kind
B2
Abstract

Provided are novel nucleotides, nucleoside, and their derivatives described herein, that can be used in DNA sequencing technology and other types of DNA analysis. In one embodiment, the nucleotide or nucleoside with an unprotected 3′-OH group is derivatized at the nucleobase to include a fluorescent dye attached via a linker to a photocleavable terminating group. The photocleavable-fluorescent group is designed to terminate DNA synthesis as well as be cleaved so that DNA oligomers can be sequenced efficiently in a parallel format. The design of such rapidly cleavable fluorescent groups on nucleotides and nucleosides can enhance the speed and accuracy of sequencing of large oligomers of DNA in parallel, to allow rapid whole genome sequencing, and the identification of polymorphisms and other valuable genetic information, as well as allowing further manipulation and analysis of nucleic acid molecules in their native state following cleavage of the fluorescent group.

Claims (24)

1. A compound according to the following formula or a salt thereof:

wherein R 1 is H, monophosphate, diphosphate, triphosphate, or alpha thiotriphosphate;

R 2 is H or OH;

the Base is cytosine, uracil, thymine, adenine, guanine, or naturally occurring derivatives thereof;

the Cleavable terminating moiety-Linker-Dye is a group of the formula:

wherein

R 3 and R 4 are each independently H, a C 1 -C 12 straight chain or branched alkyl, a C 2 -C 12 straight chain or branched alkenyl or polyenyl, a C 2 -C 12 straight chain or branched alkynyl or polyalkynyl, or an aromatic group, with the proviso that at least one of R 3 and R 4 is H;

R 5 , R 6 , R 7 and R 8 are each independently H, OCH 3 , NO 2 , CN, a halide, a C 1 -C 12 straight chain or branched alkyl, a C 2 -C 12 straight chain or branched alkenyl or polyenyl, a C 2 -C 12 straight chain or branched alkynyl or polyalkynyl, an aromatic group, or the Linker-Dye group, with the proviso that at least one of R 5 , R 6 , R 7 , and R 8 is the Linker-Dye group;

the Cleavable terminating moiety imparts polymerase termination properties to the compound and is attached to the Base by a direct bond or a linkage group;

the Linker and the linkage group are, independently, a bifunctional group; and

the Dye is a fluorophore.

2. A compound according to claim 1 , wherein the linkage group is selected from —OCH 2 —, —OC(O)—, —O—, —CH 2 C(O)—, —OC(O)OCH 2 —, and —CH 2 OC(O) —.

3. A compound according to claim 1 , wherein the compound is a formula or salt thereof selected from the group consisting of:

wherein R 1 is H, monophosphate, diphosphate, triphosphate, or alphathiotriphosphate,

R 2 is H or OH,

R 3 and R 4 are each independently H or a C 1 -C 12 straight chain or branched alkyl, with the proviso that at least one of R 3 and R 4 is H,

R 5 , R 7 , and R 8 are each independently selected from the group consisting of H, OCH 3 , NO 2 , CN, a halide, and a C 1 -C 12 straight chain or branched alkyl, and

R 6 is the Linker-Dye group, which is further defined as:

wherein X is C≡C, and

Dye is a fluorophore.

4. A compound according to claim 3 , wherein R 3 and R 4 are selected from the group consisting of —CH 3 , —CH 2 CH 3 , —CH 2 CH 2 CH 3 , isopropyl, and tert-butyl.

5. A compound-according to claim 3 , wherein the compound is selected from the group consisting of

6. The compound of claim 1 , wherein the compound is able to terminate a polymerase reaction at an efficiency between about 70% to about 100%.

7. The compound of claim 6 , wherein the compound is able to terminate a polymerase reaction at an efficiency between about 90% to about 100%.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2018
From: LASERGEN, INC.
To: AGILENT TECHNOLOGIES, INC.
Reel/Frame 047494/0278 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2018
From: WU, WEIDONG; LITOSH, VLADISLAV A.; STUPI, BRIAN P.; METZKER, MICHAEL L.
To: LASERGEN, INC.
Reel/Frame 046928/0267 →
Continuity (4)
Continuation 13114270 · May 24, 2011
Continuation 12268876 · Nov 11, 2008
Division 11567189 · Dec 5, 2006
Related Publication 20130072388A1 · Mar 21, 2013